Cargando…
AMPD1: a novel therapeutic target for reversing insulin resistance
BACKGROUND: Insulin resistance is one of the hallmark manifestations of obesity and Type II diabetes and reversal of this pathogenic abnormality is an attractive target for new therapies for Type II diabetes. A recent report that metformin, a drug known to reverse insulin resistance, demonstrated in...
Autores principales: | Cheng, Jidong, Morisaki, Hiroko, Toyama, Keiko, Sugimoto, Naomi, Shintani, Takuya, Tandelilin, Andreas, Hirase, Tetsuaki, Holmes, Edward W, Morisaki, Takayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274759/ https://www.ncbi.nlm.nih.gov/pubmed/25511531 http://dx.doi.org/10.1186/1472-6823-14-96 |
Ejemplares similares
-
AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle
por: Tandelilin, Andreas AK, et al.
Publicado: (2015) -
Erratum to: AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle
por: Tandelilin, Andreas A. K., et al.
Publicado: (2015) -
Role of AMPD2 in impaired glucose tolerance induced by high fructose diet
por: Hudoyo, Athanasius Wrin, et al.
Publicado: (2017) -
Effect of isolated AMP deaminase deficiency on skeletal muscle function()
por: Cheng, Jidong, et al.
Publicado: (2014) -
Prevalence of Dural Ectasia in Loeys-Dietz Syndrome: Comparison with Marfan Syndrome and Normal Controls
por: Kono, Atsushi K., et al.
Publicado: (2013)